Bupleurum
OTHER NAME(S): Bei Chai Hu, Bupleuri, Bupleurum Chinese, Buplèvre, Buplèvre Chinois, Buplèvre à Feuilles Rondes, Buplèvre à Feuilles de Scorsonère, Buplèvre à Longues Feuilles, Buplèvre Ligneux, Chai Hu, Chi Hu, Chinese Bupleurum, Chinese Thoroughwax, Hare's Ear Root, Radix Bupleuri, Saiko, Shrubby Hare's-ear, Sickle-leaf Hare's-ear, Thoroughwax, Thorow wax, Bupleurum chinense, Bupleurum exaltatum, Bupleurum falcatum, Bupleurum fruticosum, Bupleurum longifolium, Bupleurum multinerve, Bupleurum octoradiatum, Bupleurum rotundifolium, Bupleurum scorzonerifolium, Thorowax, Buplèvre
Overview
Bupleurum is an herb or woody shrub native to Europe, Asia, and North America. There are about 200 different species. Its root is used as medicine.
Bupleurum is included in many Chinese and Japanese traditional herbal formulas. It might help stimulate the immune system and protect the liver.
People use bupleurum for asthma, depression, flu, hepatitis, liver cancer, and many other conditions, but there is no good scientific evidence to support these uses.
Uses
We currently have no information for Bupleurum overview.
Side Effects
When taken by mouth: Bupleurum is possibly safe. It's been used as part of a Japanese herbal formula called Sho-saiko-to for up to 5 years. It's usually well-tolerated. Side effects might include nausea.
Precautions
When taken by mouth: Bupleurum is possibly safe. It's been used as part of a Japanese herbal formula called Sho-saiko-to for up to 5 years. It's usually well-tolerated. Side effects might include nausea.
Pregnancy and breast-feeding: There isn't enough reliable information to know if bupleurum is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.
Auto-immune diseases such as multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), rheumatoid arthritis (RA), or other conditions: Bupleurum might cause the immune system to become more active. This could increase the symptoms of auto-immune diseases. If you have one of these conditions, it's best to avoid using bupleurum.
Bleeding disorders: Chemicals in bupleurum might slow blood clotting. This might make bleeding disorders worse.
Diabetes: Chemicals in bupleurum might increase blood sugar levels. Monitor your blood sugar carefully if you have diabetes and use bupleurum. The dose of your diabetes medication may need to be changed.
Surgery: Chemicals in bupleurum might prolong bleeding or increase blood sugar levels. Stop taking saikosaponins at least two weeks before a scheduled surgery.
Interactions
Moderate Interaction
Be cautious with this combination
- Medications that decrease the immune system (Immunosuppressants) interacts with BupleurumBupleurum can increase the activity of the immune system. Some medications, such as those used after a transplant, decrease the activity of the immune system. Taking bupleurum along with these medications might decrease the effects of these medications.
- Medications for diabetes (Antidiabetes drugs) interacts with BupleurumChemicals in bupleurum, called saikosaponins, might increase blood sugar levels. Taking bupleurum along with diabetes medications might reduce the effects of these medications. Monitor your blood sugar closely.
- Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with BupleurumBupleurum might slow blood clotting. Taking bupleurum along with medications that also slow blood clotting might increase the risk of bruising and bleeding.
Dosing
Bupleurum is most often used by adults in combination with other ingredients in traditional medicine herbal formulas. Speak with your healthcare provider to find out what type of product and dose might be best for a specific condition.
References
- The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
- Kobashi Y, Nakajima M, Niki Y, Matsushima T. [A case of acute eosinophilic pneumonia due to Sho-saiko-to]. Nippon Kyobu Shikkan Gakkai Zasshi 1997;35:1372-7.
- Wada Y, Kubo M. [Acute lymphoblastic leukemia complicated by type C hepatitis during treatment and further by acute interstitial pneumonia due to sho-saiko-to in 7-year-old]. Arerugi 1997;46:1148-55.
- Sato A, Toyoshima M, Kondo A, et al. [Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan]. Nippon Kyobu Shikkan Gakkai Zasshi 1997;35:391-5.
- Daibo A, Yoshida Y, Kitazawa S, et al. [A case of pneumonitis and hepatic injury caused by a herbal drug (sho-saiko-to)]. Nippon Kyobu Shikkan Gakkai Zasshi 1992;30:1583-8.
- Sugiyama H, Nagai M, Kotajima F, et al. [A case of interstitial pneumonia with chronic hepatitis C following interferon-alfa and sho-saiko-to therapy]. Arerugi 1995;44:711-4.
- Ishizaki T, Sasaki F, Ameshima S, et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 1996;9:2691-6.
- Nakagawa A, Yamaguchi T, Takao T, Amano H. [Five cases of drug induced pneumonitis due to Sho-saiko-to or interferon-alpha or both]. Nippon Kyobu Shikkan Gakkai Zasshi 1995;33:1361-6.
- Miyazaki E, Ando M, Ih K, et al. [Pulmonary edema associated with the Chinese medicine shosaikoto]. Nihon Kokyuki Gakkai Zasshi 1998;36:776-80.
- Piras G, Makino M, Baba M. Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro. Microbiol Immunol 1997;41:835-9.
- Just MJ, Recio MC, Giner RM, et al. Anti-inflammatory activity of unusual lupane saponins from Bupleurum fruticescens. Planta Med 1998;64:404-7.
- Matsumoto T, Yamada H. Regulation of immune complexes binding of macrophages by pectic polysaccharide from Bupleurum falcatum L.: pharmacological evidence for the requirement of intracellular calcium/calmodulin on Fc receptor up-regulation by bupleuran 2IIb. J Pharm Pharmacol 1995;47:152-6.
- Bupleurum falcatum Bitter & cool. The Australian Naturopath Network web site. Available at: http://www.comcen.com.au/~sburgess/herbs/Monographs/bupleuru.htm
- Jing H, Jiang Y, Luo S. [Chemical constituents of the roots of Bupleurum longicaule Wall. ex DC. var. franchetii de Boiss and B. chaishoui Shan et Sheh]. Chung Kuo Chung Yao Tsa Chih 1996;21:739-41,762.
- Yen MH, Lin CC, Chuang CH, Liu SY. Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of xiao-chai-hu-tang prepared using three different Bupleurum species. J Ethnopharmacol 1991;34:155-65.
- Yamada H. [Structure and pharmacological activity of pectic polysaccharides from the roots of Bupleurum falcatum L]. Nippon Yakurigaku Zasshi 1995;106:229-37.
- Matsumoto T, Moriguchi R, Yamada H. Role of polymorphonuclear leucocytes and oxygen-derived free radicals in the formation of gastric lesions induced by HCl/ethanol, and a possible mechanism of protection by anti-ulcer polysaccharide. J Pharm Pharmacol 1993;45:535-9.
- Hattori T, Ito M, Suzuki Y. [Studies on antinephritic effects of plant components in rats (1). Effects of saikosaponins original-type anti-GBM nephritis in rats and its mechanisms]. Nippon Yakurigaku Zasshi 1991;97:13-21.
- Ahn BZ, Yoon YD, Lee YH, et al. Inhibitory effect of bupleuri radix saponins on adhesion of some solid tumor cells and relation to hemolytic action: screening of 232 herbal drugs for anti-cell adhesion. Planta Med 1998;64:220-4.
- Chang WC, Hsu FL. Inhibition of platelet activation and endothelial cell injury by flavan-3-ol and saikosaponin compounds. Prostaglandins Leukot Essent Fatty Acids 1991;44:51-6.
- Kato M, Pu MY, Isobe K, et al. Characterization of the immunoregulatory action of saikosaponin-d. Cell Immunol 1994;159:15-25.
- Ushio Y, Oda Y, Abe H. Effect of saikosaponin on the immune responses in mice. Int J Immunopharmacol 1991;13:501-8.
- Chiu HF, Lin CC, Yen MH, et al. Pharmacological and pathological studies on hepatic protective crude drugs from Taiwan (V): The effects of Bombax malabarica and Scutellaria rivularis. Am J Chin Med 1992;20:257-64.
- Izumi S, Ohno N, Kawakita T, et al. Wide range of molecular weight distribution of mitogenic substance(s) in the hot water extract of a Chinese herbal medicine, Bupleurum chinense. Biol Pharm Bull 1997;20:759-64.
- Guinea MC, Parellada J, Lacaille-Dubois MA, Wagner H. Biologically active triterpene saponins from Bupleurum fruticosum. Planta Med 1994;60:163-7.
- Martin S, Padilla E, Ocete MA, et al. Anti-inflammatory activity of the essential oil of Bupleurum fruticescens. Planta Med 1993;59:533-6.
- Lorente I, Ocete MA, Zarzuelo A, et al. Bioactivity of the essential oil of Bupleurum fruticosum. J Nat Prod 1989;52:267-72.
- Bermejo Benito P, Abad Martinez MJ, Silvan Sen AM, et al. In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci 1998;63:1147-56.
- Estevez-Braun A, Estevez-Reyes R, Moujir LM, et al. Antibiotic activity and absolute configuation of 8S-heptadeca-2(Z),9(Z)-diene-4,6-diyne-1,8-diol from Bupleurum salicifolium. J Nat Prod 1994;57:1178-82.
- Zhang H, Huang J. Preliminary study of traditional Chinese medicine treatment of minimal brain dysfunction: analysis of 100 cases. Chung Hsi I Chieh Ho Tsa Chih 1990;10:278-9, 260.
- Liang, H., Zhao, Y., Qiu, H., Huang, J., and Zhang, R. [A new saikosaponin from Bupleurum Chinese DC]. Yao Xue.Xue.Bao. 1998;33(1):37-41.
- Liang, H., Zhao, Y., Bai, Y., Zhang, R., and Tu, G. [A new saikosaponin from Bupleurum chinense DC.]. Yao Xue.Xue.Bao. 1998;33(4):282-285.
- Zhang, S., Cheng, Z., Huang, B., and Li, J. [The effect of he jie decoction on the TCRV beta 7 of chronic hepatitis B patients]. Zhong.Yao Cai. 2002;25(6):451-453.
- Hsu, Y. L., Kuo, P. L., Weng, T. C., Yen, M. H., Chiang, L. C., and Lin, C. C. The antiproliferative activity of saponin-enriched fraction from Bupleurum Kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells. Biol Pharm Bull. 2004;27(7):1112-1115.
- Ushio Y and Abe H. Inactivation of measles virus and herpes simplex virus by saikosaponin d. Planta Med 1992;58(2):171-173.
- Xie, Y., Lu, W., Cao, S., Jiang, X., Yin, M., and Tang, W. Preparation of bupleurum nasal spray and evaluation on its safety and efficacy. Chem Pharm Bull.(Tokyo) 2006;54(1):48-53.
- Sun XB, Matsumoto T, and Yamada H. Effects of a polysaccharide fraction from the roots of Bupleurum falcatum L. on experimental gastric ulcer models in rats and mice. J Pharm Pharmacol 1991;43(10):699-704.
- Cao, S. L., Chen, E., Zhang, Q. Z., and Jiang, X. G. A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch Pharm.Res 2007;30(8):1014-1019.
- Tajiri, H., Kozaiwa, K., Ozaki, Y., Miki, K., Shimuzu, K., and Okada, S. Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. Am J Chin Med 1991;19(2):121-129.
- Wu, S. J., Lin, Y. H., Chu, C. C., Tsai, Y. H., and Chao, J. C. Curcumin or saikosaponin a improves hepatic antioxidant capacity and protects against CCl4-induced liver injury in rats. J Med.Food 2008;11(2):224-229.
- He, Y., Hu, Z. F., Li, P., Xiao, C., Chen, Y. W., Li, K. M., Guo, J. Z., Pan, L., and Xiong, J. P. [Experimental study of saikosaponin-D (SSd) on lipid peroxidation of hepatic fibrosis on rat]. Zhongguo Zhong.Yao Za Zhi. 2008;33(8):915-919.
- Kakumu S, Yoshioka K, Wakita T, and et al. Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis. Int J Immunopharmacol 1991;13(2-3):141-146.
- Nose, M., Amagaya, S., and Ogihara, Y. Corticosterone secretion-inducing activity of saikosaponin metabolites formed in the alimentary tract. Chem.Pharm.Bull (Tokyo) 1989;37(10):2736-2740.
- Hirayama, C., Okumura, M., Tanikawa, K., and et al. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol Jpn 1989;24(6):715-719.
- Fujiwara K and Ogihara Y. Pharmacological effects of oral saikosaponin a may differ depending on conditions of the gastrointestinal tract. Life Sci 7-28-1986;39(4):297-301.
- Haranaka, K., Satomi, N., Sakurai, A., Haranaka, R., Okada, N., and Kobayashi, M. Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol Immunother. 1985;20(1):1-5.
- Abe H, Orita M, Konishi H, and et al. Effects of saikosaponin-d on aminonucleoside nephrosis in rats. Eur J Pharmacol 1-21-1986;120(2):171-178.
- Shimizu K, Amagaya S, and Ogihara Y. Structural transformation of saikosaponins by gastric juice and intestinal flora. J Pharmacobiodyn 1985;8(9):718-725.
- Abe, H., Sakaguchi, M., Odashima, S., and Arichi, S. Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat. Naunyn Schmiedebergs Arch.Pharmacol 1982;320(3):266-271.
- Abe H, Sakaguchi M, Anno M, and et al. Erythrocyte membrane stabilization by plant saponins and sapogenins. Naunyn Schmiedebergs Arch Pharmacol. 1981;316(3):262-265.
- Hiai S, Yokoyama H, Nagasawa T, and et al. Stimulation of the pituitary-adrenocortical axis by saikosaponin of Bupleuri radix. Chemical and Pharmaceutical Bulletin (Tokyo) 1981;29(2):495-499.
- Yokoyama H, Hiai S, and Oura H. Chemical structures and corticosterone secretion-inducing activities of saikosaponins. Chem Pharm Bull (Tokyo) 1981;29(2):500-504.
- Sugiyama H, Nagai M, Kotajima F, and et al. [A case of interstitial pneumonia with chronic hepatitis C following interferon-alfa and sho-saiko-to therapy]. Arerugi 1995;44(7):711-714.
- Duan, Y., Zhao, X., Xu, X., Yang, J., and Li, Z. Treatment of primary thrombocytopenic purpura by modified minor decoction of bupleurum. J Tradit.Chin Med. 1995;15(2):96-98.
- Motoo Y and Sawabu N. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett 10-28-1994;86(1):91-95.
- Hung CR, Wu TS, and Chang TY. Comparison between the effects of crude saikosaponin and 16, 16-dimethyl prostaglandin E2 on tannic acid-induced gastric mucosal damage in rats. Chin J Physiol 1993;36(4):211-217.
- Zong Z, Fujikawa-Yamamoto K, Tanino M, and et al. Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Biochem Biophys Res Commun 2-15-1996;219(2):480-485.
- Oka H, Yamamoto S, Kuroki T, and et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 9-1-1995;76(5):743-749.
- Kida, H., Akao, T., Meselhy, M. R., and Hattori, M. Enzymes responsible for the metabolism of saikosaponins from Eubacterium sp. A-44, a human intestinal anaerobe. Biol.Pharm.Bull 1997;20(12):1274-1278.
- Lin M, Zhang W, Su J. Toxic polyacetylenes in the genus Bupleurum (Apiaceae) - Distribution, toxicity, molecular mechanism and analysis. J Ethnopharmacol. 2016;193:566-573.
- Teschke R, Zhang L, Long H, et al. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol. 2015;14(1):7-19.
- Xiong XJ, Chu FY, Li HX, He QY. Clinical application of the TCM classic formulae for treating chronic bronchitis. J Tradit Chin Med. 2011;31(1):69-72.
- Pistelli L, Noccioli C, Giachi I, et al. Lupane-triterpenes from Bupleurum flavum. Nat Prod Res. 2005;19(8):783-8.
- Yao J, Zhang H, Ma L, et al. Effect of traditional Chinese medicine Bupleurum in the treatment of influenza A (H1N1). Pak J Pharm Sci. 2018;31(4(Special)):1713-1717.
- Yang L, Shergis JL, Di YM, et al. Managing depression with Bupleurum chinense herbal formula: a systematic review and meta-analysis of randomized controlled trials. J Altern Complement Med 2020;26(1):8-24. doi: 10.1089/acm.2019.0105.
- Meng X, Liu S, Deng X, et al. Clinical efficacy of Bupleurum inula flower soup for immune damage intervention in Hashimoto's thyroiditis: A placebo-controlled randomized trial. Front Pharmacol 2022;13:1049618.
- Kang Y, Gao Y, Li X, et al. Bupleurum chinense exerts a mild antipyretic effect on LPS-induced pyrexia rats involving inhibition of peripheral TNF-a production. J Ethnopharmacol 2023;310:116375.